ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND

ABSL Aditya Birla Sun Life Mutual Fund Jan 2022 — Sep 2026 57 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹1,055 CrAt NSE closes, Sep 2026
Companies held3939 with an NSE price
Top 10 holdings55.6%Of the equity shown here
Largest holding9.5%Torrent Pharmaceuticals Limited
12-month turnover18.6%Estimated from 12 monthly disclosures · compare

Days to sell half: 3.5 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

57 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

55.6% now, 56.2% in Sep 2025 · highest 72.3%, lowest 53.3%

Companies held

39 now, 36 in Sep 2025 · largest single holding 9.5% of equity

How long new positions last: of the 29 companies this fund started holding between Jun 2022 and Aug 2025, 97% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →

How it trades: no clear lean toward recent winners or losers (score +0.02 over 8 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. NIPPON INDIA PHARMA FUNDNippon India · 28 shared65.3%
  2. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared57.5%
  3. Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 20 shared56.6%
  4. EODWHFEdelweiss · 18 shared54.9%
  5. Mirae Asset Healthcare FundMirae Asset · 18 shared54.4%
  6. Bandhan BSE Healthcare Index FundBandhan · 36 shared54.3%
  7. Motilal Oswal BSE Healthcare ETFMotilal Oswal · 36 shared54.3%
  8. WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 23 shared53.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 0 Companies added
Complete exits 0 Companies sold out
Increases 3 More shares than last month
Reductions 0 Fewer shares than last month

New positions

CompanyShares
  1. None this month.

Complete exits

CompanyShares
  1. None this month.

Largest reductions

CompanyShares
  1. None this month.

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Torrent Pharmaceuticals Limited Healthcare Large Cap 9.47% 99.97 Cr 0.02 Cr by Jan 2022 (57 mo+)
Sun Pharmaceutical Industries Limited Healthcare Large Cap 8.79% 92.79 Cr 0.05 Cr by Jan 2022 (57 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 6.57% 69.35 Cr 84,936 by Jan 2022 (57 mo+)
Cipla Limited Healthcare Large Cap 6.51% 68.71 Cr 0.05 Cr by Jan 2022 (57 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 4.61% 48.70 Cr 0.03 Cr by Jan 2022 (57 mo+)
Sai Life Sciences Limited Healthcare Small Cap 4.58% 48.36 Cr 0.03 Cr Dec 2024 (22 mo)
Ajanta Pharma Limited Healthcare Small Cap 4.44% 46.82 Cr 0.01 Cr by Jan 2022 (57 mo+)
Mankind Pharma Limited Healthcare Mid Cap 3.69% 38.95 Cr 0.02 Cr Apr 2023 (42 mo)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 3.58% 37.77 Cr 0.02 Cr Apr 2026 (6 mo)
Abbott India Limited Healthcare Mid Cap 3.32% 35.08 Cr 12,933 by Jan 2022 (57 mo+)
Emcure Pharmaceuticals Limited Healthcare Small Cap 3.27% 34.54 Cr 0.02 Cr Jul 2024 (27 mo)
Lupin Limited Healthcare Mid Cap 3.01% 31.71 Cr 0.02 Cr by Jan 2022 (57 mo+)
IPCA Laboratories Limited Healthcare Mid Cap 2.77% 29.20 Cr 0.02 Cr Sep 2024 (25 mo)
Gland Pharma Limited Healthcare Small Cap 2.76% 29.14 Cr 0.01 Cr Jul 2025 (15 mo)
Fortis Healthcare Limited Healthcare Mid Cap 2.47% 26.10 Cr 0.03 Cr by Jan 2022 (57 mo+)
CORONA Remedies Limited Not classified Small Cap 2.32% 24.49 Cr 0.01 Cr Dec 2025 (10 mo)
Divi's Laboratories Limited Healthcare Large Cap 2.29% 24.16 Cr 26,000 May 2025 (17 mo)
Procter & Gamble Health Limited Healthcare Small Cap 1.86% 19.58 Cr 35,195 Nov 2024 (23 mo)
Thyrocare Technologies Limited Healthcare Small Cap 1.79% 18.94 Cr 0.04 Cr Jun 2025 (16 mo)
Alkem Laboratories Limited Healthcare Mid Cap 1.71% 18.09 Cr 35,039 by Jan 2022 (57 mo+)
Jupiter Life Line Hospitals Limited Not classified Small Cap 1.58% 16.66 Cr 0.07 Cr Sep 2023 (37 mo)
Metropolis Healthcare Limited Healthcare Small Cap 1.51% 15.91 Cr 0.03 Cr Feb 2025 (20 mo)
Biocon Limited Healthcare Mid Cap 1.48% 15.63 Cr 0.04 Cr Jun 2025 (16 mo)
Shilpa Medicare Limited Healthcare Small Cap 1.46% 15.39 Cr 0.01 Cr Jul 2025 (15 mo)
Piramal Pharma Limited Healthcare Small Cap 1.25% 13.18 Cr 0.06 Cr Aug 2025 (14 mo)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 1.16% 12.20 Cr 98,975 by Jan 2022 (57 mo+)
Anthem Biosciences Limited Healthcare Mid Cap 1.15% 12.16 Cr 0.01 Cr Mar 2026 (7 mo)
Sanofi Consumer Healthcare India Limited Not classified Small Cap 1.14% 12.00 Cr 31,557 Mar 2025 (19 mo)
Suraksha Diagnostic Limited Not classified Small Cap 1.13% 11.90 Cr 0.03 Cr Nov 2024 (23 mo)
Manipal Health Enterprises Limited Not classified — 1.09% 11.50 Cr 0.02 Cr Jul 2026 (3 mo)
Vijaya Diagnostic Centre Limited Healthcare Small Cap 1.07% 11.24 Cr 78,210 by Jan 2022 (57 mo+)
Pfizer Limited Healthcare Small Cap 1.03% 10.87 Cr 28,058 Aug 2025 (14 mo)
Natco Pharma Limited Healthcare Small Cap 0.94% 9.93 Cr 0.01 Cr Aug 2026 (2 mo)
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 0.85% 8.97 Cr 32,390 Feb 2025 (20 mo)
Medi Assist Healthcare Services Limited Not classified Small Cap 0.75% 7.90 Cr 0.03 Cr Jan 2024 (33 mo)
Vinati Organics Limited Not classified Small Cap 0.71% 7.47 Cr 63,971 Dec 2022 (46 mo)
Syngene International Limited Healthcare Small Cap 0.65% 6.91 Cr 0.02 Cr Jun 2026 (4 mo)
Max Healthcare Institute Limited Healthcare Large Cap 0.62% 6.51 Cr 70,000 May 2025 (17 mo)
Jubilant Pharmova Limited Healthcare Small Cap 0.62% 6.49 Cr 63,087 Jul 2025 (15 mo)

Half of its current holdings have been held for 23 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Cipla Limited Sep 2026 ▲ Increasing +0.01 Cr
Biocon Limited Sep 2026 ▲ Increasing +0.01 Cr
Dr. Lal Path Labs Ltd. Sep 2026 ▲ Increasing +70,339
Shilpa Medicare Limited Aug 2026 ▼ Reducing -0.03 Cr
Natco Pharma Limited Aug 2026 ▲ New position +0.01 Cr
Cipla Limited Aug 2026 ▲ Increasing +72,000
Sun Pharmaceutical Industries Limited Aug 2026 ▼ Reducing -15,261
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -0.02 Cr
Manipal Health Enterprises Limited Jul 2026 ▲ New position +0.02 Cr
Sun Pharmaceutical Industries Limited Jul 2026 ▼ Reducing -0.01 Cr
Cipla Limited Jul 2026 ▲ Increasing +0.01 Cr
Torrent Pharmaceuticals Limited Jul 2026 ▲ Increasing +0.01 Cr
Biocon Limited Jul 2026 ▲ Increasing +45,564
Sai Life Sciences Limited Jul 2026 ▲ Increasing +30,737
Metropolis Healthcare Limited Jul 2026 ▲ Increasing +25,000
Dr. Lal Path Labs Ltd. Jul 2026 ▲ Increasing +22,000
Syngene International Limited Jun 2026 ▲ New position +0.02 Cr
Alembic Pharmaceuticals Limited Jun 2026 ▼ Complete exit -0.02 Cr
Shilpa Medicare Limited Jun 2026 ▼ Reducing -0.01 Cr
Sai Life Sciences Limited Jun 2026 ▲ Increasing +0.01 Cr
Gland Pharma Limited Jun 2026 ▲ Increasing +50,000
Vinati Organics Limited Jun 2026 ▲ Increasing +16,749
Dr. Lal Path Labs Ltd. Jun 2026 ▲ Increasing +16,000
Piramal Pharma Limited May 2026 ▲ Increasing +60,000
Jubilant Pharmova Limited May 2026 ▼ Reducing -53,799
Fortis Healthcare Limited May 2026 ▼ Reducing -38,553
Cipla Limited May 2026 ▼ Reducing -25,000
Dr. Lal Path Labs Ltd. May 2026 ▲ Increasing +19,500
IPCA Laboratories Limited May 2026 ▼ Reducing -17,000
Pfizer Limited May 2026 ▲ Increasing +2,500
Gland Pharma Limited May 2026 ▲ Increasing +517
GlaxoSmithKline Pharmaceuticals Limited May 2026 ▼ Reducing -407
Alembic Pharmaceuticals Limited May 2026 ▼ Reducing -10
Dr. Lal Path Labs Ltd. Apr 2026 ▲ New position +62,256
IPCA Laboratories Limited Apr 2026 ▼ Reducing -51,643
Mankind Pharma Limited Apr 2026 ▲ Increasing +30,000
Anthem Biosciences Limited Mar 2026 ▲ New position +0.01 Cr
Mankind Pharma Limited Mar 2026 ▲ Increasing +25,000
Procter & Gamble Health Limited Mar 2026 ▲ Increasing +9,685
Sanofi Consumer Healthcare India Limited Mar 2026 ▲ Increasing +8,010
Pfizer Limited Mar 2026 ▲ Increasing +7,408
Procter & Gamble Health Limited Feb 2026 ▲ Increasing +6,510
Sanofi Consumer Healthcare India Limited Feb 2026 ▲ Increasing +2,171
Piramal Pharma Limited Jan 2026 ▲ Increasing +0.01 Cr
Cipla Limited Jan 2026 ▼ Reducing -0.01 Cr
Shilpa Medicare Limited Jan 2026 ▲ Increasing +70,000
Jubilant Pharmova Limited Jan 2026 ▲ Increasing +22,000
Sanofi Consumer Healthcare India Limited Jan 2026 ▲ Increasing +2,223
Pfizer Limited Jan 2026 ▲ Increasing +1,650
CORONA Remedies Limited Dec 2025 ▲ New position +0.01 Cr
Sun Pharmaceutical Industries Limited Dec 2025 ▲ Increasing +75,000
Shilpa Medicare Limited Dec 2025 ▲ Increasing +60,000
Lupin Limited Dec 2025 ▼ Reducing -40,000
Cipla Limited Dec 2025 ▼ Reducing -40,000
Alembic Pharmaceuticals Limited Dec 2025 ▼ Reducing -24,237
GlaxoSmithKline Pharmaceuticals Limited Dec 2025 ▼ Reducing -8,200
Anthem Biosciences Limited Nov 2025 ▼ Complete exit -0.02 Cr
Aurobindo Pharma Limited Nov 2025 ▲ Increasing +70,000
J.B. Chemicals & Pharmaceuticals Lt Nov 2025 ▲ Increasing +66,546
Thyrocare Technologies Limited Nov 2025 ▼ Reducing -60,000
Shilpa Medicare Limited Oct 2025 ▲ Increasing +0.03 Cr
Anthem Biosciences Limited Oct 2025 ▼ Reducing -0.02 Cr
Fortis Healthcare Limited Oct 2025 ▼ Reducing -0.01 Cr
Thyrocare Technologies Limited Sep 2025 ▲ Increasing +6,300
Pfizer Limited Sep 2025 ▲ Increasing +1,500
Piramal Pharma Limited Aug 2025 ▲ New position +0.04 Cr
Sai Life Sciences Limited Aug 2025 ▼ Reducing -70,000
Fortis Healthcare Limited Aug 2025 ▼ Reducing -50,000
Aurobindo Pharma Limited Aug 2025 ▼ Reducing -50,000
Shilpa Medicare Limited Aug 2025 ▲ Increasing +20,200
Sanofi India Limited Aug 2025 ▼ Complete exit -19,296
Pfizer Limited Aug 2025 ▲ New position +15,000
Jubilant Pharmova Limited Aug 2025 ▲ Increasing +14,014
Thyrocare Technologies Limited Aug 2025 ▲ Increasing +12,000
Vinati Organics Limited Aug 2025 ▲ Increasing +8,270
Sanofi Consumer Healthcare India Limited Aug 2025 ▲ Increasing +482
Anthem Biosciences Limited Jul 2025 ▲ New position +0.04 Cr
Akums Drugs and Pharmaceuticals Limited Jul 2025 ▼ Complete exit -0.02 Cr
Biocon Limited Jul 2025 ▼ Reducing -0.01 Cr
Shilpa Medicare Limited Jul 2025 ▲ New position +93,282
Jubilant Pharmova Limited Jul 2025 ▲ New position +80,872
Thyrocare Technologies Limited Jul 2025 ▲ Increasing +65,000
Alembic Pharmaceuticals Limited Jul 2025 ▼ Reducing -54,997
Cipla Limited Jul 2025 ▼ Reducing -50,000
Gland Pharma Limited Jul 2025 ▲ New position +50,000
Torrent Pharmaceuticals Limited Jul 2025 ▼ Reducing -30,900
GlaxoSmithKline Pharmaceuticals Limited Jul 2025 ▼ Reducing -11,321
Sun Pharmaceutical Industries Limited Jul 2025 ▼ Reducing -5,180
Abbott India Limited Jul 2025 ▼ Reducing -3,361
Biocon Limited Jun 2025 ▲ New position +0.04 Cr
Thyrocare Technologies Limited Jun 2025 ▲ New position +54,893
GlaxoSmithKline Pharmaceuticals Limited Jun 2025 ▼ Reducing -17,457
Alkem Laboratories Limited Jun 2025 ▼ Reducing -14,731
Torrent Pharmaceuticals Limited Jun 2025 ▼ Reducing -7,000
Sun Pharmaceutical Industries Limited May 2025 ▼ Reducing -0.01 Cr
Suraksha Diagnostic Limited May 2025 ▲ Increasing +94,808
Max Healthcare Institute Limited May 2025 ▲ New position +70,000
Aurobindo Pharma Limited May 2025 ▼ Reducing -70,000
Divi's Laboratories Limited May 2025 ▲ New position +26,000
Torrent Pharmaceuticals Limited May 2025 ▼ Reducing -19,643

Changes compare consecutive month-end disclosures for this portfolio only.